The federal contract award summarized details a delivery order for GEMTESA 75 MG TABLET 90S, valued at $8,876.48, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). This contract is a firm fixed-price delivery order with a completion date of December 26, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty medications, generic drugs, vaccines, and medical devices, to federal agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation. The company holds significant Indefinite Delivery Contracts (IDCs) with these agencies, valued at up to $999,999,999 and $750,000, respectively, to provide comprehensive pharmaceutical and medical supply support to military, veterans, and other federal healthcare programs.
Generated 3/25/25, 9:45 AM